Stemtech Corporation (STEK) Research

Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.

Market snapshot

Symbol
STEK
Price
$0.00
Day change
+33.33%
Market cap
$29.2K
P/E ratio
-0.01x
52-week range
0.0001-0.0346
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Dynatronics Corporation (DYNT)
  • American Green, Inc. (ERBB)
  • Radiko Holdings Corp. (GEATF)
  • Global Roundtable Corporation (GRCU)
  • Gold River Productions, Inc. (GRPS)
  • NeutriSci International Inc. (NRXCF)
  • Stemsation International, Inc. (STSN)
  • Maven Brands Inc. (TRLFF)

Recent insider activity

  • KAPLAN BENJAMIN NATHANIEL — S-Sale (1000000 shares) on 2025-06-23
  • ARNOLD CHARLES STUART — P-Purchase (25000 shares) on 2024-07-26
  • Mindshare Holdings, Inc. — S-Sale (25000 shares) on 2024-04-19
  • Green Darryl V — A-Award (1254818 shares) on 2023-08-08
  • Green Darryl V — A-Award (2408818 shares) on 2023-06-12

Open Stemtech Corporation (STEK) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.